Kearney, NE. - SCORR Marketing, a global full-service marketing and communications firm, in partnership with Applied Clinical Trials, conducted a survey of clinical trial project managers to gain a better understanding of the level of company support they need and receive, the culture of their organizations and the biggest challenges they face in their jobs. “As the complexity of clinical trials increases, the demand for more proficient project managers increases as well,” said Cliff Echols, market intelligence director at SCORR. “The goal of this survey was to gain insight into the expectations and responsibilities of project managers that have been added as a result of the evolving nature of clinical trials.” The report details project managers’ current and desired levels of company support and training, and availability and importance of career development opportunities. It also reveals the most valuable skill sets for project managers to possess and their most challenging responsibilities. Survey respondents included program managers with varying levels of experience from international pharmaceutical companies, CROs, academic institutions, biotech companies and research sites. “Sponsors can use the results of this survey to make more insightful decisions and build stronger relationships with project management teams,” said Lisa Henderson, editor in chief at Applied Clinical Trials. About SCORR Marketing SCORR Marketing is the leading marketing and communications firm in the health sciences industry. We partner with organizations involved in global research, development and commercialization of biopharmaceutical and device products and the delivery of health care products and services. At SCORR, we achieve results for our clients by applying our proven, disciplined approach to synthesize market intelligence, strategy and creativity. We have locations across North America and Europe. For more information, visit www.scorrmarketing.com.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.